Summary
Updated Aug 30, 2026
Ryan J. Selhorn is Chief Financial Officer of AYTU BIOPHARMA, INC (AYTU). 3 SEC Form 4 filings on record going back to 2024, most recently on 30 July 2026.
Recent Transactions
4Every recent SEC Form 4 transaction Ryan J. Selhorn has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Ryan J. Selhorn's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Jason P. Rhodes - $124.92M of DYN open-market activity in the last 12 months
- Stephen M. Bloch - $118.66M of LQDA open-market activity in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $117.62M of ARTV open-market activity in the last 12 months
- SVF Pauling (Cayman) Ltd - $116.40M of RLAY open-market activity in the last 12 months
- Bain Capital Life Sciences Investors, LLC - $115.00M of HTFL open-market activity in the last 12 months
- Herriot Tabuteau - $110.58M of AXSM open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Ryan J. Selhorn?
Ryan J. Selhorn is a corporate insider, tracked as Chief Financial Officer of AYTU BIOPHARMA, INC (AYTU). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Ryan J. Selhorn submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Ryan J. Selhorn's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Ryan J. Selhorn and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
